TABLE 1.
Gene Name |
Type of hearing loss |
Prevalen ce in affected |
Patent holder |
Type of Test |
No of providersa | Price of Test ($)b | ||
---|---|---|---|---|---|---|---|---|
NonPr ofit |
For Profit |
NonPr ofit |
For Profit |
|||||
GJB2 | Non syndromic | >50%i | Institut Pasteur US 5998147 US 6485908 | Full sequence Analysis | 181 | 472.35c Athena (362–818) Preventiond Diagnostics | 575 290 |
|
GJB6 | Non syndromic | 7–16%j | N/A | Deletion Analysis | 61 | 300.25e 295 (161–534) | ||
SLC26A4 | Syndromic | 4–10%k | N/A | Full sequence Analysis | 60 | 1686f N/A (1100–2507) | ||
MTRNR1 | Mitochondrial Non syndromic | <1%i | Cedars-Sinai US 5506101 | Targeted mutation | 82 | 210g h (150–285) | 248 365 |
|
MTTS1 | Mitochondrial Non syndromic | <1%i | N/A | Targeted mutation | 40 | 238 N/A (150–285) |
Providers for specific test type identified from Genetests (see http://www.genetests.org) are current as of January 2009.
List prices of tests obtained from phone survey March 2007 or test laboratory web site
Average list price for 14 out of 17 providers offering full sequence analysis
Prices of 2 separate for-profit providers in 2008. Preventions Diagnostics is no longer listed on GeneTests as of January 2009.
Average list price for 4 out of 7 providers
Average list price for 4 out of 6 providers, not including NIH which offers testing free of charge to research participants
Average list price for 6 out of 8 providers
Prices of 2 separate for-profit providers